Effects of the periocular botulinum toxin on the ocular surface and anterior chamber: a prospective study in patients with hemifacial spasm and blepharospasm

Int Ophthalmol. 2023 Aug;43(8):2731-2736. doi: 10.1007/s10792-023-02672-8. Epub 2023 Apr 26.

Abstract

Purpose: To analyze using Pentacam®, the corneal and anterior chamber changes following periocular botulinum toxin injection in patients with facial dystonia.

Methods: Prospective study that included patients with facial dystonia that were going to receive a periocular botulinum toxin injection for the first time or six months or more after the previous injection. A Pentacam® examination was carried out in all patients before and 4 weeks after the injection.

Results: Thirty-one eyes were included. Twenty-two had a diagnosis of blepharospasm and nine of hemifacial spasm. Analysis of corneal and anterior chamber parameters revealed a significant decrease in iridocorneal angle after botulinum toxin injection (from 35 ± 10º to 33.8 ± 9.7º, p = 0.022). No other corneal or anterior chamber parameters changed significantly after the injection.

Conclusions: Periocular botulinum toxin injection causes narrowing of the iridocorneal angle.

Keywords: Acute angle-closure; Botulinum toxin; Facial dystonia; Pentacam.

MeSH terms

  • Anterior Chamber
  • Blepharospasm* / drug therapy
  • Botulinum Toxins* / adverse effects
  • Botulinum Toxins, Type A* / adverse effects
  • Dystonia* / drug therapy
  • Hemifacial Spasm* / drug therapy
  • Humans
  • Injections, Intraocular
  • Prospective Studies

Substances

  • Botulinum Toxins
  • Botulinum Toxins, Type A